PTP4A3 and prostate carcinoma: PRL-3 was also present on both mRNA and protein levels in the prostate cancer cell lines DU145 and PC3, and inhibition of PRL-3 by a small molecular inhibitor induced growth arrest and inhibited migration in the prostate cancer cells in a dose-dependent manner.